Literature DB >> 25252070

Novel mutation in the TMPRSS6 gene with iron-refractory iron deficiency anemia.

Koya Kodama1, Atsuko Noguchi, Hiroyuki Adachi, Miwa Hebiguchi, Michihiro Yano, Tsutomu Takahashi.   

Abstract

Iron-refractory iron deficiency anemia (IRIDA) is a rare autosomal recessive disease characterized by congenital hypochromic microcytic anemia, low transferrin saturation, low serum iron, normal-high serum ferritin, and increased hepcidin. This disease is caused by loss-of-function mutations in TMPRSS6 that lead to high hepcidin and result in severe anemia. We report our experience with an 11-year-old Japanese girl with hypochromic microcytic anemia, low serum iron, and high serum ferritin, with anemia that was refractory to the oral iron that was prescribed frequently from early childhood. Presence of high hepcidin suggested a diagnosis of IRIDA, which was eventually confirmed by identification of a novel homozygous mutation, p.Pro354Leu, in the TMPRSS6 gene. This case suggests that serum hepcidin should be routinely measured for differential diagnosis when patients with IDA are unresponsive to oral iron or have unusual clinical features.
© 2014 Japan Pediatric Society.

Entities:  

Keywords:  TMPRSS6; hepcidin; iron refractory iron deficiency anemia

Mesh:

Substances:

Year:  2014        PMID: 25252070     DOI: 10.1111/ped.12395

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  4 in total

1.  The catalytic, stem, and transmembrane portions of matriptase-2 are required for suppressing the expression of the iron-regulatory hormone hepcidin.

Authors:  Peizhong Mao; Aaron M Wortham; Caroline A Enns; An-Sheng Zhang
Journal:  J Biol Chem       Date:  2018-12-17       Impact factor: 5.157

2.  The ectodomain of matriptase-2 plays an important nonproteolytic role in suppressing hepcidin expression in mice.

Authors:  Caroline A Enns; Shall Jue; An-Sheng Zhang
Journal:  Blood       Date:  2020-08-20       Impact factor: 22.113

Review 3.  Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review.

Authors:  Jing Liu; Bingbing Sun; Huijun Yin; Sijin Liu
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

4.  Iron Refractory Iron Deficiency Anemia in Dizygotic Twins Due to a Novel TMPRSS6 Gene Mutation in Addition to Polymorphisms Associated With High Susceptibility to Develop Ferropenic Anemia.

Authors:  Joana Pinto; Gustavo Nobre de Jesus; Mónica Palma Anselmo; Lúcia Gonçalves; Daniela Brás; João Madeira Lopes; João Meneses; Rui Victorino; Paula Faustino
Journal:  J Investig Med High Impact Case Rep       Date:  2017-04-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.